Purchases and Sales Made in Q3 2024 in Vaneck ETF Tr Vaneck Pharmaceu (PPH)
This table provides information about the institutional ownership of Vaneck ETF Tr Vaneck Pharmaceu (PPH) during Q3 2024. The information is specifically focused on institutions that hold shares of VANECK ETF TR VANECK PHARMACEU.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 14, 2024
Q3 2024
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-2.25K- 41.9% |
$204K - $224K
|
3.12K
$274K
|
|
Jan 08, 2025
Q3 2024
|
Buska Wealth Management, LLC
Wausau, WI |
SELL
|
- |
-2.28K- 29.54% |
$206K - $227K
|
5.44K
$478K
|
|
Oct 30, 2024
Q3 2024
|
Financial Partners Group, Inc
Overland Park, KS |
SELL
|
- |
-2.34K- 2.46% |
$212K - $233K
|
92.8K
$8.15M
|
|
Oct 11, 2024
Q3 2024
|
Redhawk Wealth Advisors, Inc.
Minneapolis, MN |
SELL
|
- |
-2.69K- 53.84% |
$244K - $267K
|
2.31K
$203K
|
|
Oct 15, 2024
Q3 2024
|
Vontobel Holding Ltd.
|
SELL
|
- |
-3K- 44.12% |
$272K - $298K
|
3.8K
$334K
|
|
Nov 15, 2024
Q3 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-3.26K- 73.56% |
$296K - $324K
|
1.17K
$103K
|
|
Nov 05, 2024
Q3 2024
|
Prime Capital Investment Advisors, LLC
Overland Park, KS |
SELL
|
- |
-4.85K- 3.61% |
$439K - $482K
|
129K
$11.4M
|
|
Nov 13, 2024
Q3 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-6.5K- 25.1% |
$589K - $646K
|
19.4K
$1.71M
|
|
Nov 08, 2024
Q3 2024
|
Atria Wealth Solutions, Inc.
New York, NY |
SELL
|
- |
-7.07K- 64.22% |
$641K - $703K
|
3.94K
$346K
|
|
Nov 12, 2024
Q3 2024
|
Wintrust Investments LLC
Chicago, IL |
SELL
|
- |
-7.41K- 90.01% |
$671K - $737K
|
823
$72.3K
|
|
Nov 14, 2024
Q3 2024
|
Level Four Advisory Services, LLC
Dallas, TX |
SELL
|
- |
-8.78K- 22.15% |
$795K - $873K
|
30.9K
$2.71M
|
|
Nov 14, 2024
Q3 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-25.4K- 47.15% |
$2.3M - $2.53M
|
28.5K
$2.5M
|
|
Oct 09, 2024
Q3 2024
|
Private Advisory Group LLC
Redmond, WA |
SELL
|
- |
-32.3K- 84.94% |
$2.92M - $3.21M
|
5.72K
$503K
|
|
Dec 26, 2024
Q3 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-146K- 93.87% |
$13.2M - $14.5M
|
9.54K
$839K
|
|
Nov 08, 2024
Q3 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-146K- 93.87% |
$13.2M - $14.5M
|
9.54K
$839K
|